Hogan Lovells Publications

Massachusetts anti-opioid law bans manufacturer copay assistance

On Thursday, August 9, 2018, Massachusetts Gov. Charlie Baker (R) signed H.4742, "An Act for prevention and access to appropriate care and treatment of addiction," which takes effect...

Hogan Lovells Publications

China drug regulator calling on international pharmaceutical companies to bring “urgently-needed” new drugs to China

On 8 August 2018, in an unprecedented regulatory action, the China National Drug Administration (CNDA) called on international pharmaceutical companies to bring 48 new drugs to China. These ...

Published Works

340B Program Restatements and Refunds: A whitepaper by Hogan Lovells and Deloitte Risk and Financial Advisory

It is a time of change in the 340B Program. Manufacturers should closely monitor 340B Program developments and prepare to respond promptly and effectively to changes in legal requirements....

Published Works

Wearable Medical Devices Raise Issues for Physicians

Counsel Stephanie Carman authored an article titled: "Wearable Medical Devices Raise Issues for Physicians" for the South Florida Legal Guide

Hogan Lovells Publications

Private health care reform

Proposed changes tabled by the South African Competition Commission 

Hogan Lovells Publications

U.S. House legislation highlights escalating government-wide focus on opioid abuse

On June 22 the U.S. House of Representatives passed sweeping legislation that represents "the biggest effort Congress has ever undertaken" to address the opioid epidemic, according to Rep....

Loading data